Anti‐idiotype vaccines

This publication has 91 references indexed in Scilit:

• Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-β1 and interleukin-10
  Blood, 2001
• Sustaining the graft-versus-tumor effect through posttransplant immunization with granulocyte-macrophage colony-stimulating factor (GM-CSF)–producing tumor vaccines
  Blood, 2000
• Vaccination of Seronegative Volunteers with a Human Immunodeficiency Virus Type 1env/revDNA Vaccine Induces Antigen‐Specific Proliferation and Lymphocyte Production of β‐Chemokines
  The Journal of Infectious Diseases, 2000
• Deletion of Idiotype (Id)-Specific T Cells in Multiple Myeloma
  Acta Oncologica, 2000
• Complete molecular remissions induced by patient-specific vaccination plus granulocyte–monocyte colony-stimulating factor against lymphoma
  Nature Medicine, 1999
• DNA Vaccination: Transfection and Activation of Dendritic Cells as Key Events for Immunity
  The Journal of Experimental Medicine, 1999
• Dendritic cells and the control of immunity
  Nature, 1998
• Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells.
  Journal of Clinical Investigation, 1997
• Naive CD4⁺ T cells confer idiotype‐specific tumor resistance in the absence of antibodies
  European Journal of Immunology, 1995
• Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon
  Blood, 1989